Drug repurposing: Clemastine fumarate and neurodegeneration
Neurodegenerative diseases have been a weighty problem in elder people who might be stricken with motor or/and cognition defects with lower life quality urging for effective treatment. Drugs are costly from development to market, so that drug repurposing, exploration of existing drugs for novel ther...
Main Authors: | Jiahui Zhu, Rong Ma, Gang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222012938 |
Similar Items
-
Clemastine fumarate attenuates intestinal ischemia-reperfusion injury in mice
by: LIU Yang, LU Ya-peng, HAO Wei, ZHONG Hai-lian, LIU Jie-ting, WANG Ying-bin
Published: (2022-09-01) -
Repurposing Clemastine to Target Glioblastoma Cell Stemness
by: Michael A. Sun, et al.
Published: (2023-09-01) -
Drug-Repurposing Strategy for Dimethyl Fumarate
by: Salvatore Giunta, et al.
Published: (2023-07-01) -
Insights on therapeutic potential of clemastine in neurological disorders
by: Sufang Jiang, et al.
Published: (2023-09-01) -
The Challenge of Dimethyl Fumarate Repurposing in Eye Pathologies
by: Federico Manai, et al.
Published: (2022-12-01)